Sigma Planning Corp’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387K | Sell |
276,777
-28,398
| -9% | -$39.8K | 0.01% | 882 |
|
|
2025
Q1 | $540K | Buy |
305,175
+68,965
| +29% | +$122K | 0.02% | 701 |
|
|
2024
Q4 | $543K | Buy |
236,210
+23,800
| +11% | +$54.7K | 0.02% | 711 |
|
|
2024
Q3 | $752K | Buy |
212,410
+86,185
| +68% | +$305K | 0.02% | 592 |
|
|
2024
Q2 | $350K | Buy |
126,225
+58,240
| +86% | +$161K | 0.01% | 859 |
|
|
2024
Q1 | $451K | Buy |
67,985
+51,405
| +310% | +$341K | 0.01% | 801 |
|
|
2023
Q4 | $50.5K | Buy |
+16,580
| New | +$50.5K | ﹤0.01% | 829 |
|